● Recruiting

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

Condition: B-cell Malignancy · Marginal Zone Lymphoma · Follicular Lymphoma · Sponsor: BeOne Medicines

PhasePhase 1/Phase 2

Planned participants645

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Study consists of two main parts to explore BGB-16673 recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalation and monotherapy safety expansion of selected doses, and a Phase 2 (expansion cohorts)

This description comes directly from the study's public registry record.

Talk to the study team

BeOne Medicines · 1.877.828.5568 · clinicaltrials@beonemed.com

Study Director, MD

Always discuss trial participation with your own doctor first.

Locations (127)

University of Alabama At Birmingham Hospital	Birmingham, Alabama, United States	Recruiting
Mayo Clinic Phoenix	Phoenix, Arizona, United States	Completed
Honor Health Research Institute	Scottsdale, Arizona, United States	Recruiting
University of Arizona Cancer Center	Tucson, Arizona, United States	Recruiting
University of California San Diego (Ucsd) Moores Cancer Center	La Jolla, California, United States	Recruiting
Stanford Medicine	Palo Alto, California, United States	Recruiting
UCLA Santa Monica Cancer Care	Santa Monica, California, United States	Recruiting
Uchealth North	Fort Collins, Colorado, United States	Recruiting
Mayo Clinic Jacksonville	Jacksonville, Florida, United States	Recruiting
Mount Sinai Medical Center Braman Comprehensive Cancer Center	Miami, Florida, United States	Recruiting
Tampa General Hospital Cancer Institute	Tampa, Florida, United States	Recruiting
Augusta University	Augusta, Georgia, United States	Recruiting

+ 115 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05006716